Alessandro Passardi Department of Medical Oncology Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Biography Publications Institution JoVE Articles Alessandro Passardi has not added a biography. If you are Alessandro Passardi and would like to personalize this page please email our Author Liaison for assistance. Publications Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine? International Journal of Molecular Sciences. Nov, 2018 | Pubmed ID: 30477151 Circulating Plasma Levels of MiR-20b, MiR-29b and MiR-155 As Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer International Journal of Molecular Sciences. Jan, 2018 | Pubmed ID: 29361687 Immune Checkpoints As a Target for Colorectal Cancer Treatment International Journal of Molecular Sciences. Jun, 2017 | Pubmed ID: 28635639 Relationship Between Hypoxia and Response to Antiangiogenic Therapy in Metastatic Colorectal Cancer Oncotarget. Jul, 2016 | Pubmed ID: 27081084 Prognostic Role of Serum Concentrations of High-sensitivity C-reactive Protein in Patients with Metastatic Colorectal Cancer: Results from the ITACa Trial Oncotarget. Mar, 2016 | Pubmed ID: 26848624 Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer PloS One. 2015 | Pubmed ID: 26244985 Détection d’un Panel de micro-ARN Custom circulant chez les Patients atteints de Cancer Colorectal métastatique Matteo Canale1, Giorgia Marisi1, Alessandro Passardi2, Emanuela Scarpi3, Paola Ulivi1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 3Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 58615 Cancer Research
Détection d’un Panel de micro-ARN Custom circulant chez les Patients atteints de Cancer Colorectal métastatique Matteo Canale1, Giorgia Marisi1, Alessandro Passardi2, Emanuela Scarpi3, Paola Ulivi1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 3Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 58615 Cancer Research
